OALSpecialty Chemicals
Oriental Aromatics Limite — Cash Flow Statement
₹238.25
-0.23%
Oriental Aromatics Limite Cash Flow Statement (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Free Cash Flow | -121.33 Cr | 42.44 Cr | -69.00 Cr | -60.31 Cr | — |
| Capital Expenditure | -87.04 Cr | -99.37 Cr | -46.70 Cr | -59.49 Cr | — |
| End Cash Position | 10.59 Cr | 10.63 Cr | 15.99 Cr | 6.61 Cr | — |
| Beginning Cash Position | 10.63 Cr | 15.99 Cr | 6.61 Cr | 15.39 Cr | — |
| Changes In Cash | -0.04 Cr | -5.36 Cr | 9.38 Cr | -8.77 Cr | — |
| Financing Cash Flow | 120.76 Cr | -48.20 Cr | 78.15 Cr | 51.48 Cr | — |
| Interest Paid Cff | -23.60 Cr | -20.98 Cr | -8.83 Cr | -3.98 Cr | — |
| Cash Dividends Paid | -1.68 Cr | -1.68 Cr | — | -5.05 Cr | -8.41 Cr |
| Net Issuance Payments Of Debt | 146.76 Cr | -24.84 Cr | 87.63 Cr | 61.16 Cr | — |
| Net Short Term Debt Issuance | 124.78 Cr | -45.03 Cr | 92.63 Cr | 11.16 Cr | — |
| Net Long Term Debt Issuance | 21.98 Cr | 20.19 Cr | -5.00 Cr | 50.00 Cr | — |
| Investing Cash Flow | -86.50 Cr | -98.97 Cr | -46.47 Cr | -59.44 Cr | — |
| Net PPE Purchase And Sale | -86.50 Cr | -98.97 Cr | -46.47 Cr | -59.44 Cr | — |
| Sale Of PPE | 0.53 Cr | 0.40 Cr | 0.23 Cr | 0.05 Cr | — |
| Purchase Of PPE | -87.04 Cr | -99.37 Cr | -46.70 Cr | -59.49 Cr | — |
| Operating Cash Flow | -34.29 Cr | 141.80 Cr | -22.30 Cr | -0.81 Cr | — |
| Taxes Refund Paid | -15.16 Cr | -3.36 Cr | -10.01 Cr | -22.44 Cr | — |
| Change In Working Capital | -114.86 Cr | 91.47 Cr | -70.72 Cr | -75.69 Cr | — |
| Change In Payable | -1.90 Cr | -1.57 Cr | 6.71 Cr | 11.99 Cr | — |
| Change In Inventory | -87.43 Cr | 90.56 Cr | -80.80 Cr | -59.35 Cr | — |
| Change In Receivables | -25.53 Cr | 2.47 Cr | 3.37 Cr | -28.33 Cr | — |
| Other Non Cash Items | 24.44 Cr | 19.04 Cr | 10.94 Cr | 3.18 Cr | — |
| Provisionand Write Offof Assets | 0.10 Cr | 0.00 | 0.02 Cr | 0.37 Cr | — |
| Depreciation And Amortization | 23.68 Cr | 19.79 Cr | 19.43 Cr | 17.01 Cr | — |
| Amortization Cash Flow | 2.19 Cr | 1.61 Cr | 0.87 Cr | 0.41 Cr | — |
| Depreciation | 21.49 Cr | 18.18 Cr | 18.56 Cr | 16.60 Cr | — |
| Pension And Employee Benefit Expense | -1.18 Cr | -0.08 Cr | — | — | — |
| Gain Loss On Investment Securities | 0.12 Cr | 0.02 Cr | 0.03 Cr | 0.17 Cr | — |
| Net Foreign Currency Exchange Gain Loss | 0.96 Cr | 0.86 Cr | 2.73 Cr | 0.51 Cr | — |
| Gain Loss On Sale Of PPE | 0.12 Cr | 0.02 Cr | 0.03 Cr | 0.17 Cr | — |
| Net Income From Continuing Operations | 47.61 Cr | 14.05 Cr | 27.48 Cr | 75.88 Cr | — |
| Repayment Of Debt | — | — | — | — | -7.65 Cr |
| Common Stock Dividend Paid | — | — | — | — | -8.41 Cr |
| Long Term Debt Payments | — | — | — | — | -7.65 Cr |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Oriental Aromatics Limite
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.